CT1812 Biomarker Signature from a Meta-Analysis of CSF Proteomic Findings from Two Phase 2 Clinical Trials in Alzheimer's Disease.
ALZHEIMERS & DEMENTIA（2024）
关键词
Alzheimer's disease,A beta oligomers,clinical trial,CSF pharmacodynamic biomarkers,CT1812,investigational therapeutic,TMT-MS proteomics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要